PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Dracorhodin 20 Drug Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
Dracorhodin 20 Drug Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
BRSK1 20 Target Disease Cholesterol 182,390 1 0.00 -0.97 0.05 0.56
4-1BB Receptor 20 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
4-1BB Receptor 20 Target Disease Infection 766,637 2 0.00 -0.95 0.10 0.55
Dracorhodin 20 Drug Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
Amitiza (Lubiprostone)- FDA 19 Drug Drug Alprostadil (Prostin VR Pediatric)- FDA 26 14 0.63 -0.35 0.74 0.96
Doxacurium Chloride 19 Drug Drug Doxacurium 85 19 0.47 -0.20 1.00 0.91
AMAC-1 19 Target Target DC-CK1 22 4 0.20 -0.80 0.21 0.90
Aralen (Chloroquine)- FDA 19 Drug Drug Atovaquone (Mepron)- FDA 11 3 0.21 -0.78 0.27 0.90
Aralen (Chloroquine)- FDA 19 Drug Drug Acitretin (Soriatane)- FDA 13 2 0.13 -0.87 0.15 0.88
Amitiza (Lubiprostone)- FDA 19 Drug Drug Alosetron Hydrochloride (Lotronex)- FDA 27 2 0.09 -0.91 0.11 0.86
AMAC-1 19 Target Target CCL18 256 4 0.06 -0.88 0.21 0.79
Aralen (Chloroquine)- FDA 19 Drug Drug Acetaminophen (Tylenol)- FDA 69 1 0.03 -0.97 0.05 0.79
Eotaxin-2/CCL24 19 Target Target CCL8 197 1 0.02 -0.97 0.05 0.75
Eotaxin-2/CCL24 19 Target Target CCL1 220 1 0.02 -0.97 0.05 0.74
Amitiza (Lubiprostone)- FDA 19 Drug Disease Irritable Bowel Syndrome 8,230 14 0.04 -0.51 0.74 0.71
ALK Phos 19 Target Target CD146 729 1 0.01 -0.97 0.05 0.70
Amitiza (Lubiprostone)- FDA 19 Drug Disease Constipation 15,810 16 0.03 -0.40 0.84 0.69
Tegument Protein Vp16 19 Target Disease Genital Herpes 2,660 2 0.01 -0.95 0.11 0.68
AMAC-1 19 Target Target CCL3 1,427 1 0.01 -0.97 0.05 0.68
Eotaxin-2/CCL24 19 Target Target CCL3 1,427 1 0.01 -0.97 0.05 0.68
Doxacurium Chloride 19 Drug Drug Droperidol 1,957 1 0.01 -0.97 0.05 0.67
Kaad-Cyclopamine 19 Drug Target Activin A 2,048 1 0.01 -0.97 0.05 0.67
Doxacurium Chloride 19 Drug Disease Muscle Relaxation 4,706 2 0.01 -0.95 0.11 0.67
AMAC-1 19 Target Target Eotaxin 2,457 1 0.00 -0.97 0.05 0.66
AMAC-1 19 Target Target CCL2 3,560 1 0.00 -0.97 0.05 0.65
ALK Phos 19 Target Disease Skin Rash 3,684 1 0.00 -0.97 0.05 0.65
AMAC-1 19 Target Disease Septic Arthritis 4,121 1 0.00 -0.97 0.05 0.65
Aralen (Chloroquine)- FDA 19 Drug Drug Doxycycline 9,324 2 0.00 -0.95 0.11 0.65
Eotaxin-2/CCL24 19 Target Disease Inflammatory Bowel Diseases 4,684 1 0.00 -0.97 0.05 0.65
AMAC-1 19 Target Target CCL4 5,638 1 0.00 -0.97 0.05 0.64
Kaad-Cyclopamine 19 Drug Disease Basal Cell Carcinoma 7,953 1 0.00 -0.97 0.05 0.63
Aralen (Chloroquine)- FDA 19 Drug Disease Malaria 56,215 7 0.01 -0.79 0.37 0.63
Kaad-Cyclopamine 19 Drug Disease Glioblastoma 17,933 2 0.00 -0.95 0.11 0.63
Amitiza (Lubiprostone)- FDA 19 Drug Disease Ileus 9,091 1 0.00 -0.97 0.05 0.63
AMAC-1 19 Target Target CD14 9,941 1 0.00 -0.97 0.05 0.63
Complement Decay-Accelerating Factor 19 Target Disease Chronic Lymphocytic Leukemia 11,642 1 0.00 -0.97 0.05 0.62
Kallikrein-8 19 Target Disease Psoriasis 26,882 2 0.00 -0.95 0.11 0.62
Complement Decay-Accelerating Factor 19 Target Target CEA 17,022 1 0.00 -0.97 0.05 0.61
Kallikrein-8 19 Target Disease Glioblastoma 17,933 1 0.00 -0.97 0.05 0.61
Kaad-Cyclopamine 19 Drug Target ERK1 18,374 1 0.00 -0.97 0.05 0.61
Complement Decay-Accelerating Factor 19 Target Target Calmodulin 25,240 1 0.00 -0.97 0.05 0.60
Eotaxin-2/CCL24 19 Target Disease Psoriasis 26,882 1 0.00 -0.97 0.05 0.60
Eotaxin-2/CCL24 19 Target Disease Asthma 109,610 4 0.00 -0.89 0.21 0.60
Kaad-Cyclopamine 19 Drug Target EGF 27,487 1 0.00 -0.97 0.05 0.60
Dropropizine 19 Drug Disease Sedation 27,984 1 0.00 -0.97 0.05 0.60
Aralen (Chloroquine)- FDA 19 Drug Disease Infectious Diseases 33,605 1 0.00 -0.97 0.05 0.60
Kaad-Cyclopamine 19 Drug Disease Ovarian Cancer 33,996 1 0.00 -0.97 0.05 0.60
AMAC-1 19 Target Disease Osteoarthritis 36,287 1 0.00 -0.97 0.05 0.60